Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Seikagaku claims new drugs for osteoporosis

Aug. 13, 2007

Recent patent claims novel short peptides for the treatment of endometriosis

Aug. 13, 2007

Tercica granted marketing approval for Increlex in the E.U.

Aug. 9, 2007

Top-line results for MicroDose's glucose clamp study of QDose insulin inhaler

Aug. 9, 2007

Unigene begins clinical study of oral calcitonin for osteoporosis

Aug. 9, 2007

Central effects of adiponectin on food intake elucidated

Aug. 9, 2007

Paget's disease indication submitted for risedronate sodium hydrate as orphan drug

Aug. 8, 2007

Rheoscience and Dr. Reddy's begin phase III study of balaglitazone

Aug. 7, 2007

Genta and Emisphere submit IND for oral G-4544 formulation

Aug. 7, 2007

MacroGenics initiates three clinical trials with teplizumab in type 1 diabetes

Aug. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...